TGT
44
4
URBN
56
5
VMC
68
3
K
63
3
EXC
69
-3
EQR
51
4
BF.B
47
-3
AME
54
4
DRI
77
5
PPL
75
-2
NRG
69
17
GS
58
-7
PSX
47
3
NWL
45
4
KIM
64
6
SWK
39
-3
CMI
55
4
ABT
63
3
MSI
55
8
OI
43
-2
TGT
44
4
URBN
56
5
VMC
68
3
K
63
3
EXC
69
-3
EQR
51
4
BF.B
47
-3
AME
54
4
DRI
77
5
PPL
75
-2
NRG
69
17
GS
58
-7
PSX
47
3
NWL
45
4
KIM
64
6
SWK
39
-3
CMI
55
4
ABT
63
3
MSI
55
8
OI
43
-2
Financhill
Back

EyePoint Pharmaceuticals Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
33

EYPT
EyePoint Pharmaceuticals

Last Price:
$6.23
Seasonality Move:
16.96%
Buy
60

ALNY
Alnylam Pharmaceuticals

Last Price:
$280.77
Seasonality Move:
3.3%
Sell
33
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $6.34. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $6.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $290.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 45.37 Sell
Chaikin Money Flow: -580139 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6 - 6.88) Sell
Bollinger Bands (100): (6.36 - 9.76) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.72 Buy
Relative Strength Index (14 RSI): 71.41 Buy
Chaikin Money Flow: -979016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.44 - 263) Buy
Bollinger Bands (100): (240.32 - 271.8) Buy

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.38 Sell
20-day SMA: 6.48 Sell
50-day SMA: 6.94 Sell
200-day SMA: 8.5 Sell
8-day EMA: 6.39 Sell
20-day EMA: 6.52 Sell
50-day EMA: 6.95 Sell
200-day EMA: 9.12 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 257.74 Buy
20-day SMA: 249.75 Buy
50-day SMA: 257.54 Buy
200-day SMA: 251.5 Buy
8-day EMA: 263.89 Buy
20-day EMA: 256.08 Buy
50-day EMA: 255.39 Buy
200-day EMA: 243.44 Buy

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):